Publications by authors named "H Soejima"

Background: Machine learning (ML) techniques are widely employed across various domains to achieve accurate predictions. This study assessed the effectiveness of ML in predicting early mortality risk among patients with acute intracerebral hemorrhage (ICH) in real-world settings.

Methods And Results: ML-based models were developed to predict in-hospital mortality in 527 patients with ICH using raw brain imaging data from brain computed tomography and clinical data.

View Article and Find Full Text PDF

Beckwith-Wiedemann syndrome (BWS) is caused by a gain of methylation (GOM) at the imprinting control region within the Igf2-H19 domain on the maternal allele (H19-ICR GOM). Mutations in the binding sites of several transcription factors are involved in H19-ICR GOM and BWS. However, the responsible sequence(s) for H19-ICR GOM with BWS-like overgrowth has not been identified in mice.

View Article and Find Full Text PDF
Article Synopsis
  • Multi-locus imprinting disturbance (MLID) affects methylation in certain genes and has been identified in about 150 cases of imprinting disorders, with inadequate previous research on this condition aside from one study on specific syndromes.
  • In a study of 783 patients, 29 individuals with confirmed epimutations displayed MLID, found in 12% of those with Beckwith-Wiedemann syndrome (BWS) and 5% with Silver-Russell syndrome (SRS), but not in other syndromes.
  • Further analysis revealed abnormal methylation patterns and deleterious genetic variants in mothers of MLID patients, with around 50% of MLID patients experiencing neurodevelopmental delays or intellectual disorders, indicating
View Article and Find Full Text PDF
Article Synopsis
  • The JPAD trial studied the long-term effects of low-dose aspirin on gastrointestinal symptoms and bleeding in diabetic patients, comparing those taking aspirin to those not taking it.
  • Among 2535 participants, the aspirin group experienced a significantly higher rate of gastrointestinal issues, with 8.8% compared to 5.7% in the no-aspirin group at 18 years.
  • The risk was notably higher within the first 3 years, particularly for buffered aspirin, suggesting that these factors should influence decisions on starting and continuing low-dose aspirin for prevention.
View Article and Find Full Text PDF